Brief: Endo launches testosterone nasal gel
March 16 (Reuters) - Endo International PLC ENDP.O : * Announces the launch of Natesto (testosterone nasal gel), the first and only nasal gel for testosterone replacement therapy * Says will collaborate with Trimel on all regulatory and clinical development activities regarding natesto * Source text for Eikon ID:nPrewpBHxa * Further company coverage ENDP.O ((Bengaluru Newsroom; +1 646 223 8780))
Recent news on Trilogy International Partners
See all newsBrief: Trilogy International Partners Says SG Enterprises II Gave Letter To Special Committee Of Co Non-Binding LOI
Brief: Trilogy International Appoints Andrew Davies To Board Of Co
Brief: MarketWise Announces Appointment Of Erik Mickels As Chief Financial Officer
Brief: Trilogy International Partners Erik Mickels Senior Vice President, CFO Resigned
Media: Trilogy sells New Zealand telco stake in $1.2 bln deal - Bloomberg News